JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"

Final dividend in cash for the year ended December 31, 2024

Final dividend in cash for the year ended December 31, 2024

DISCLOSEABLE TRANSACTION SUBSCRIPTION OF FURTHER FINANCIAL PRODUCTS

DISCLOSEABLE TRANSACTION SUBSCRIPTION OF FURTHER FINANCIAL PRODUCTS

Notification Letter and Reply Form For Non-Registered Holders

Notification Letter and Reply Form For Non-Registered Holders

Notification Letter and Reply Form For Registered Holders

Notification Letter and Reply Form For Registered Holders

2024 Environmental, Social and Governance Report

2024 Environmental, Social and Governance Report

DISCLOSEABLE TRANSACTION SUBSCRIPTION OF FURTHER FINANCIAL PRODUCTS

DISCLOSEABLE TRANSACTION SUBSCRIPTION OF FURTHER FINANCIAL PRODUCTS

VOLUNTARY ANNOUNCEMENT UNUSUAL PRICE MOVEMENT

VOLUNTARY ANNOUNCEMENT UNUSUAL PRICE MOVEMENT

Leave us a message

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Message

Message

top